Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage
| Image |  |
|---|---|
| Description | scientific article published on 5 October 2017 |
| Author/s | |
| Publication date | October 5, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |